{"schema_version":"secwatch.filing_event.v1","accession":"0000320017-22-000008","form_type":"8-K","ticker":"LSTA","cik":"0000320017","company_name":"LISATA THERAPEUTICS, INC.","filed_at":"2022-02-25T23:59:59+00:00","discovered_at":"2026-05-14T18:04:09.232837+00:00","generated_at":"2026-06-27T04:21:37.907179+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Caladrius Biosciences Chief Legal Officer Todd Girolamo resigns effective March 14","bullets":["Todd Girolamo resigns as Chief Legal Officer, SVP Corporate Development, and Corporate Secretary.","Resignation effective March 14, 2022; reason is to pursue other career opportunities.","No replacement named as of the filing date."],"urls":{"canonical":"https://secwatch.observer/filing/0000320017-22-000008","json":"https://secwatch.observer/filing/0000320017-22-000008.json","markdown":"https://secwatch.observer/filing/0000320017-22-000008.md","text":"https://secwatch.observer/filing/0000320017-22-000008.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/320017/000032001722000008/0000320017-22-000008-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/320017/000032001722000008/clbs-20220224.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T04:21:37.907179+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bb597fb186","claim":"Todd C. Girolamo resigned as Chief Legal Officer at LISATA THERAPEUTICS, INC..","evidence_excerpt":"On February 24, 2022, Todd C. Girolamo, Esq., Chief Legal Officer, Senior Vice President of Corporate Development and Corporate Secretary of Caladrius Biosciences, Inc. (the “Company”), notified the Company of his intent to resign from all positions held with the Company in order to pursue other career opportunities.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/320017/000032001722000008/0000320017-22-000008-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Legal Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}